MannKind | MNKD - Current Assets

Stock Price
6.15
Daily Change
0.14 2.38%
Monthly
9.48%
Yearly
10.07%
Q1 Forecast
5.60

MannKind reported $358.84M in Current Assets for its fiscal quarter ending in September of 2025.





Current Assets Change Date
Adma Biologics USD 402.66M 3.1M Sep/2025
Dynavax Technologies USD 814.33M 28.62M Sep/2025
Eli Lilly USD 62.07B 12.22B Sep/2025
Halozyme Therapeutics USD 1.33B 206.08M Sep/2025
Insmed USD 1.93B 149.77M Sep/2025
MacroGenics USD 232.09M 27.15M Sep/2025
MannKind USD 358.84M 79.81M Sep/2025
Merck USD 47.56B 10.49B Sep/2025
Novo Nordisk DKK 25.71B 148.69B Jun/2025
Pfizer USD 46.92B 3.22B Sep/2025
Sanofi EUR 30.95B 3.09B Dec/2025
Xencor USD 518.44M 5.29M Sep/2025